Outbreak Intelligence Brief: Ebola Activity in East & Central Africa (2026)

Ebola remains a critical public health priority in East and Central Africa, with recent confirmed infections in Uganda linked to cross-border transmission from the Democratic Republic of the Congo (DRC). While case numbers remain limited, the situation underscores the ongoing need for rapid diagnostics, coordinated surveillance, and resilient laboratory networks. Situation Overview.

Uganda • Health authorities have confirmed new Ebola cases, all epidemiologically linked to movement across the DRC border. • Uganda has activated border screening, contact tracing, and community-level surveillance to prevent further spread. • Rapid response teams are deployed in high-risk districts to reinforce infection prevention and control (IPC).

Democratic Republic of the Congo • The DRC continues to manage a persistent Ebola outbreak, with cases concentrated in regions with limited healthcare access. • Control measures include: o Enhanced surveillance and real-time case investigation o Isolation and treatment centers near outbreak clusters o Community engagement programs to improve reporting and reduce transmission o Cross-border coordination with Uganda, Rwanda, and South Sudan • Security challenges and population mobility remain barriers to containment.

Diagnostics Implications Ebola outbreaks highlight the urgent need for: • Decentralized molecular testing for rapid triage • High-sensitivity assays suitable for low-resource settings • Integrated surveillance systems linking hospitals, border posts, and national labs • Clear clinical algorithms for differentiating Ebola from malaria, typhoid, and other febrile illnesses These dynamics create both operational challenges and strategic opportunities for diagnostics manufacturers, investors, and health system partners.

---

How GRN IVD Consulting Supports Stakeholders At GRN IVD Consulting, we help organizations navigate outbreak-driven market shifts with clarity and precision: 🔹 Market intelligence on emerging infectious disease testing needs 🔹 Competitive landscape analysis across molecular, immunoassay, and POC platforms 🔹 Clinical algorithm mapping for high-consequence pathogens 🔹 Commercial strategy support for companies entering or expanding in outbreak-relevant markets 🔹 Investor-grade insights on technology readiness, adoption barriers, and regional demand signals As outbreaks evolve, diagnostics innovation becomes a frontline defense. GRN IVD Consulting ensures your strategy is aligned with real-world needs, global trends, and clinical realities.